info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Pain Management Companies

Companies involved in pain management contribute to the development, manufacturing, and distribution of products and services aimed at alleviating and managing pain. Pain management encompasses a broad spectrum, including pharmaceuticals, medical devices, therapeutic interventions, and supportive care.

Pain Management Key Companies

 

Latest Pain Management Companies Update


Acorda Therapeutics Phase 3 study evaluating INBRIJA® (dexmedetomidine injection) for the treatment of moderate-to-severe acute low back pain is ongoing. Positive results could expand access to this non-opioid option for pain relief.


Neurolief non-invasive spinal cord stimulation device for chronic neuropathic pain is undergoing a pivotal Phase 3 trial. This technology offers a promising alternative to traditional neurostimulation methods with its ease of use and potentially fewer side effects.


Pfizer Ibogaine-derived drug candidate, PF-05251765, is in early-stage clinical trials for the treatment of neuropathic pain. This novel therapy targets the N-methyl-D-aspartate (NMDA) receptor, potentially offering a new approach to pain management.


Johnson & Johnson acquires Abiomed acquisition strengthens J&J's pain management portfolio with Abiomed's novel spinal cord stimulation technologies.


Stryker Corporation partners with Verily Life Sciences (Alphabet subsidiary) collaboration aims to develop AI-powered solutions for personalized pain management, leveraging Verily's expertise in data analytics and Stryker's medical device technology.


List of Pain Management Key Companies in the Market




  • Abbott Laboratories




  • Stryker Corporation




  • Codman And Shurtleff, Inc




  • F. Hoffmann-La Roche Ltd




  • Abbvie




  • Allergan




  • AstraZeneca plc




  • Bayer AG




  • DJO LLC




  • Eli Lilly & Company




  • Endo Health Solution




Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.